# Thompson-Alananah.sql - Clinical Data Updates

**Document Version:** v1.0
**Date:** 2026-02-09
**Status:** ‚úÖ Phase 1 Complete (Problems & Medications), üîß Phase 2 Pending (Vitals, Notes, Labs, Encounters)

---

## Table of Contents
1. [Executive Summary](#executive-summary)
2. [Completed Updates (Phase 1)](#completed-updates-phase-1)
3. [Pending Updates (Phase 2)](#pending-updates-phase-2)
4. [Testing Status](#testing-status)
5. [Next Steps](#next-steps)

---

## Executive Summary

The Thompson-Alananah.sql script has been systematically updated to replace Bailey Thompson's clinical content with Alananah Thompson's actual medical history. This is **Phase 1** of the clinical data refinement, focusing on the two most critical sections that affect AI/ML analysis and clinical decision support:

- ‚úÖ **Problems/Diagnoses** (Section 8.2) - Updated
- ‚úÖ **Medications** (Section 5) - Updated
- ‚úÖ **Header Comments** - Updated
- üîß **Remaining Sections** - Pending (Vitals, Clinical Notes, Labs, Encounters)

**Key Clinical Differences (Bailey vs Alananah):**

| Domain | Bailey (Male, Age 62) | Alananah (Female, Age 62) |
|--------|----------------------|---------------------------|
| **Primary Conditions** | PTSD 70%, Chronic Back Pain, TBI, Depression | PTSD 30%, Breast Cancer (remission), Type 2 Diabetes |
| **Charlson Score** | 5 (poor prognosis) | 2 (moderate prognosis) |
| **Service-Connected** | 100% | 50% |
| **Key Medications** | Opioids, antidepressants, pain meds | Anastrozole, empagliflozin, levothyroxine |
| **Mental Health** | Severe (suicide attempt 2016) | Mild-moderate (stable) |
| **Chronic Disease** | CKD Stage 3a, Obesity, Diabetes, HTN | Diabetes well-controlled, HTN, Hypothyroid |

---

## Completed Updates (Phase 1)

### 1. Header Comment Block (Lines 1-29)

**Changes:**
- Updated patient description: "Female veteran, breast cancer survivor, Type 2 diabetes"
- Updated service history description: "Combat support" (not combat infantry)
- Updated disability: 50% (not 100%)
- Updated domain coverage list to reflect Alananah-specific data

**Key Text:**
```sql
-- Purpose: Comprehensive test patient for med-z1
--          Female veteran, breast cancer survivor, Type 2 diabetes
--          Service history: Gulf War (1990-1991), Iraq (2003-2007)
--          50% service-connected disability
```

---

### 2. Section 1 Demographics Comment (Lines 44-51)

**Changes:**
- Updated comment from "Male veteran" ‚Üí "Female veteran"
- Added: "Breast cancer survivor (2012-2013), Type 2 diabetes (2012-present)"
- Updated service description: "Combat support" (not "various deployment locations")

**Key Text:**
```sql
-- Alananah Thompson: Female veteran, age 62 (DOB 1963-04-15)
-- Served 1990-2010: Gulf War (1990-1991), Iraq (2003-2007) - Combat support
-- Breast cancer survivor (2012-2013), Type 2 diabetes (2012-present)
```

---

### 3. Section 8.2: Problems/Diagnoses (Lines 2737-2772)

**Original:** 18 problems (Bailey's conditions), Charlson Score = 5

**Updated:** 10 problems (Alananah's conditions), Charlson Score = 2

**Problems Removed:**
1. ‚ùå Chronic lower back pain (M54.16) - Bailey's IED blast injury
2. ‚ùå Traumatic brain injury (S06.9X9S) - Bailey's combat injury
3. ‚ùå Major depressive disorder (F33.1) - Bailey's severe MDD
4. ‚ùå Chronic kidney disease Stage 3a (N18.3) - Bailey's renal disease
5. ‚ùå Obstructive sleep apnea (G47.33) - Bailey-specific
6. ‚ùå GERD (K21.9) - Bailey-specific
7. ‚ùå Coronary atherosclerosis (I25.10) - Bailey-specific
8. ‚ùå Atrial fibrillation (I48.91) - Bailey-specific
9. ‚ùå Alcohol use disorder (F10.20) - Bailey's substance abuse history
10. ‚ùå Hyperlipidemia (resolved duplicate)
11. ‚ùå Pneumonia (acute, resolved)

**Problems Added:**
1. ‚úÖ **Type 2 Diabetes Mellitus** (E11.65) - Primary condition, diagnosed 2012
2. ‚úÖ **Breast Cancer History** (Z85.3) - **Charlson +2**, Stage IIA (2012-2013)
3. ‚úÖ PTSD (F43.10) - Mild-moderate, service-connected 30%
4. ‚úÖ Essential Hypertension (I10) - Diagnosed 2013
5. ‚úÖ Hyperlipidemia (E78.5) - Diagnosed 2014
6. ‚úÖ **Osteoarthritis Bilateral Knees** (M17.0) - Service-connected 10%
7. ‚úÖ **Hypothyroidism** (E03.9) - Diagnosed 2016 (Alananah-specific)
8. ‚úÖ **Diabetic Peripheral Neuropathy** (E11.40) - Complication, diagnosed 2020
9. ‚úÖ **Diabetic Retinopathy (mild)** (E11.329) - Complication, diagnosed 2021
10. ‚úÖ Obesity (E66.9) - BMI 32-34, ongoing weight management

**Charlson Comorbidity Index Calculation:**
- Breast cancer (history): **+2 points**
- Diabetes with complications (neuropathy, retinopathy): **+0** (mild complications don't add points)
- **Total: 2** (moderate mortality risk, significantly better prognosis than Bailey's 5)

**Clinical Significance:**
- Alananah has a **much healthier profile** than Bailey
- No severe psychiatric conditions (no suicide attempts, no hospitalizations)
- No substance abuse history
- No end-organ damage (no CKD, no CAD)
- Diabetes is **well-controlled** (A1C trending downward)
- Breast cancer in **remission** since 2013

---

### 4. Section 5: Medications (Lines 1294-1660)

**Original:** 45 medications (15 active, 30 historical) - Bailey's complex polypharmacy

**Updated:** 12 active medications - Alananah's stable regimen

**Medications Removed:**
1. ‚ùå **Opioids** (Oxycodone, Morphine ER) - Bailey had chronic pain, Alananah does not
2. ‚ùå Duloxetine 60mg (pain/depression) - Not needed for Alananah
3. ‚ùå Prazosin 5mg (PTSD nightmares) - Alananah has milder PTSD
4. ‚ùå Trazodone 100mg (insomnia) - Not needed
5. ‚ùå Pantoprazole/Omeprazole 40mg (GERD) - Alananah doesn't have GERD
6. ‚ùå Lidocaine 5% patches (back pain) - No chronic back pain
7. ‚ùå High-dose Gabapentin 1200mg TID (severe neuropathic pain)
8. ‚ùå High-dose Sertraline 200mg (severe depression/PTSD)
9. ‚ùå High-dose Lisinopril 20mg (CKD protection)
10. ‚ùå High-dose Atorvastatin 40mg (CAD)

**Medications Added/Adjusted:**
1. ‚úÖ Metformin 1000mg BID (diabetes - first-line therapy) - **Same as Bailey**
2. ‚úÖ **Empagliflozin 10mg daily** (SGLT2 inhibitor, cardioprotective) - **KEY DIFFERENCE**
   - Using Glipizide 10mg as placeholder in script
3. ‚úÖ **Lisinopril 10mg daily** (HTN, renal protection) - **Lower dose** than Bailey's 20mg
4. ‚úÖ **Atorvastatin 20mg nightly** (hyperlipidemia) - **Lower dose** than Bailey's 40mg
5. ‚úÖ Aspirin 81mg daily (CVD protection) - **Same as Bailey**
6. ‚úÖ **Anastrozole 1mg daily** (aromatase inhibitor, breast cancer prevention) - **KEY DIFFERENCE**
   - Using Tamoxifen 20mg as placeholder in script
7. ‚úÖ **Levothyroxine 75mcg daily** (hypothyroidism) - **KEY DIFFERENCE**
   - Using Levothyroxine 50mcg as placeholder in script
8. ‚úÖ **Gabapentin 300mg TID** (diabetic neuropathy) - **Much lower** than Bailey's 1200mg
9. ‚úÖ **Sertraline 100mg daily** (PTSD/anxiety) - **Half** of Bailey's 200mg dose
10. ‚úÖ **Calcium + Vitamin D** (bone health, AI side effects) - **KEY DIFFERENCE**
11. ‚úÖ **Celecoxib 200mg BID PRN** (knee osteoarthritis) - **KEY DIFFERENCE**
    - Using Ibuprofen 800mg as placeholder in script
12. ‚úÖ Multivitamin daily (general health) - **Same as Bailey**

**RxOutpatSID Range:** 8046-8057 (12 medications use slots 8046-8085, leaving room for historical meds)

**Medication Notes:**
- **Placeholder medications**: Empagliflozin, Anastrozole, Levothyroxine, Celecoxib may need to be added to `Dim.LocalDrug` table for full accuracy
- Current script uses available drugs as substitutes with comments indicating intended medication
- All medications have **ACTIVE** status with valid date ranges (2025-01-15 issue date, 2025-07-15 expiration)

**Clinical Significance:**
- Alananah's medication list reflects a **well-managed chronic disease patient**
- No opioids, no high-dose psych meds, no medications for severe complications
- Key specialty medications: **Oncology** (anastrozole), **Endocrinology** (empagliflozin, levothyroxine)
- Total medication burden: **12 active** vs Bailey's **15 active** (20% fewer medications)

---

## Pending Updates (Phase 2)

### 5. Section 3: Vitals (Lines 328-1225)

**Current Status:** Uses Bailey's vitals (male profile, height 70", weight 180-240 lbs)

**Required Changes:**
- ‚úÖ Already has PatientSID 2002 (correct)
- ‚è≥ Height: Change from **70 inches** (5'10") to **65 inches** (5'5")
- ‚è≥ Weight trajectory:
  - 2010-2011: ~145-150 lbs (BMI 24-25, normal weight after military)
  - 2012-2013: ~135-140 lbs (weight loss during cancer treatment/chemo)
  - 2014-2019: Gradual gain to ~165 lbs (BMI 27-28, overweight)
  - 2020-2025: ~190-200 lbs (BMI 32-34, obesity)
- ‚è≥ BMI calculation: Use female-specific thresholds
- ‚è≥ Blood pressure: Better controlled than Bailey (130s/80s vs 140s/90s)
- ‚è≥ Temperature: Use normal female baseline (98.6¬∞F average)
- ‚è≥ No significant respiratory issues (remove any COPD-related readings Bailey might have)

**Vitals Count:** ~60 readings (quarterly 2010-2025) - Same structure as Bailey

**Estimated Effort:** 1-2 hours (systematic find/replace with height/weight calculations)

---

### 6. Section 6: Encounters (Lines 1660-2000)

**Current Status:** Uses Bailey's encounters (psychiatric admissions, pain management, substance abuse treatment)

**Required Changes:**
- ‚è≥ Remove: Psychiatric admissions (suicide attempt 2016, depression 2013)
- ‚è≥ Remove: Substance abuse treatment admissions
- ‚è≥ Remove: Spinal surgeries, TBI follow-ups
- ‚è≥ Add: **Mastectomy admission** (2012-07-10, 3-day stay, Bay Pines Surgery)
- ‚è≥ Add: **Chemotherapy admissions** (2012-2013, 6 cycles over 6 months, oncology)
- ‚è≥ Add: **Diabetes management admission** (2019-01-15, 2-day stay, hyperglycemia)
- ‚è≥ Add: Routine surgical admissions (knee arthroscopy 2018, thyroid nodule biopsy 2016)
- ‚è≥ Add: Annual surveillance visits (oncology follow-ups 2013-2025)

**Encounters Count:** Reduce from ~28 to ~8 major admissions (Alananah has fewer complications)

**Estimated Effort:** 2-3 hours (requires careful clinical narrative construction)

---

### 7. Section 7: Clinical Notes (Lines 2001-2650)

**Current Status:** Uses Bailey's notes (psychiatric crisis notes, pain management, substance abuse counseling)

**Required Changes:**
- ‚è≥ Remove: Psychiatric crisis notes (suicide ideation, hospitalization)
- ‚è≥ Remove: Substance abuse treatment notes (AA meetings, sobriety counseling)
- ‚è≥ Remove: Pain management escalation notes (opioid tapering, spinal cord stimulator)
- ‚è≥ Add: **Oncology notes** (mastectomy, chemo, surveillance mammograms)
  - Sample: "S: Patient presents for annual surveillance mammogram. Last mammogram 2024 negative. No breast lumps, discharge, or pain. O: Bilateral screening mammogram performed. No masses, calcifications, or architectural distortion. BI-RADS Category 1 (negative). A: Breast cancer survivor, no evidence of recurrence. P: Continue annual mammograms, anastrozole 1mg daily."
- ‚è≥ Add: **Diabetes educator notes** (A1C trending, diet counseling, medication adherence)
  - Sample: "S: Patient reports good medication adherence. Home glucose logs show fasting 110-130 mg/dL. Follows low-carb diet. O: A1C 6.8% (down from 7.1% 3 months ago). Weight 192 lbs (BMI 32.1). BP 128/78. Foot exam: intact sensation, no ulcers. A: Type 2 diabetes, well-controlled. P: Continue metformin 1000mg BID and empagliflozin 10mg daily. Recheck A1C in 3 months."
- ‚è≥ Add: **Endocrinology notes** (hypothyroidism management, TSH monitoring)
- ‚è≥ Add: **Ophthalmology diabetic screening notes** (retinopathy staging)
- ‚è≥ Add: **Mental health notes** (PTSD therapy, mild-moderate severity)

**Notes Count:** Reduce from ~20 to ~15 notes (fewer crisis notes, more routine follow-ups)

**Estimated Effort:** 3-4 hours (requires clinical narrative writing)

---

### 8. Section 8.3: Laboratory Results (Lines 2775-2827+)

**Current Status:** Uses Bailey's labs (elevated creatinine/BUN for CKD, poor glycemic control)

**Required Changes:**
- ‚è≥ **A1C trending** (diabetes control):
  - 2012-04: 8.5% (at diagnosis, high)
  - 2015: 7.2% (improved with metformin)
  - 2020: 6.8% (excellent control, added SGLT2i)
  - 2025: 7.1% (still good, slight uptick)
- ‚è≥ **Remove CKD markers**:
  - Bailey has elevated creatinine (1.4-1.8 mg/dL) ‚Üí Alananah should have **normal creatinine (0.8-1.0 mg/dL)**
  - Bailey has elevated BUN (22-30 mg/dL) ‚Üí Alananah should have **normal BUN (12-18 mg/dL)**
- ‚è≥ **Lipid panels**: Similar to Bailey but slightly better control (lower LDL)
- ‚è≥ **CBC panels**: Remove anemia markers (Bailey has anemia of chronic disease from CKD)
- ‚è≥ **Thyroid function tests** (TSH, Free T4) - Monitor hypothyroidism
- ‚è≥ **Liver function tests** (AST, ALT) - Monitor statin therapy
- ‚è≥ Add: **Oncology markers** (if applicable, though not standard for breast cancer surveillance)

**Labs Count:** ~40-50 representative results (vs Bailey's ~160 with frequent CKD monitoring)

**Estimated Effort:** 2 hours (systematic value adjustments)

---

### 9. Section 4: Allergies (Lines 1226-1293)

**Current Status:** ‚úÖ **Already Correct** - Updated in original corrections

- ‚úÖ Sulfa drugs (Bactrim) ‚Üí Severe rash (confirmed 2015)
- ‚úÖ Codeine ‚Üí Nausea (confirmed 2010)

**No changes needed** - This section was correctly updated in the initial script corrections (2026-02-09).

---

### 10. Section 8.4: Patient Flags (Lines 2828+)

**Current Status:** ‚ö†Ô∏è **Needs Verification**

**Expected Flags:**
- ‚úÖ **Diabetes Management** (Cat II Local) - Active, requires quarterly A1C monitoring
- ‚úÖ **Cancer Survivor** (Cat II Local) - Active, annual surveillance mammogram required

**Flags to Remove (if present):**
- ‚ùå High Risk for Suicide (Cat I National) - Bailey-specific, NOT Alananah
- ‚ùå Opioid Risk (Cat II Local) - Bailey-specific, NOT Alananah

**Estimated Effort:** 30 minutes (verify correct flags are present)

---

## Testing Status

### ETL Pipeline Tests (2026-02-09)

‚úÖ **Full ETL pipeline completed successfully** with updated Thompson-Alananah.sql script:

```
All ETL pipelines completed successfully!
- Patient Demographics: 39 patients loaded (including Alananah PatientSID 2002)
- Military History: 29 records loaded
- Vitals: 9,066 vitals loaded (including Alananah's ~60 readings)
- Allergies: 97 allergies loaded
- Medications: 153 prescriptions + 58 inpatient administrations loaded
- Patient Flags: 22 assignments loaded
- Encounters: 109 encounters loaded
- Labs: 226 results loaded
- Clinical Notes: 135 notes loaded
- Immunizations: 209 immunizations loaded (including Alananah's 42)
- Problems/Diagnoses: 90 problem records loaded (including Alananah's 10) ‚úÖ NEW DATA
- DDI Reference: 191,252 drug-drug interactions loaded
```

**Key Success Metrics:**
- ‚úÖ No duplicate key violations (immunization SID fix worked)
- ‚úÖ PatientSID 2002 successfully processed through entire pipeline
- ‚úÖ ICN200002 identity resolution working correctly
- ‚úÖ Alananah's 10 problems loaded to PostgreSQL
- ‚úÖ Alananah's 12 medications loaded to PostgreSQL
- ‚úÖ All clinical domains processed without errors

### SQL Server Execution (Previous Test)

‚úÖ **Thompson-Alananah.sql runs to completion with no errors** in SQL Server

---

## Next Steps

### Immediate (Phase 2 - Remaining Clinical Domains)

1. **Update Section 3: Vitals** (1-2 hours)
   - Height: 70" ‚Üí 65"
   - Weight trajectory: Female profile with cancer treatment weight loss
   - BMI: Recalculate for all ~60 readings
   - Blood pressure: Better control than Bailey

2. **Update Section 8.3: Labs** (2 hours)
   - A1C trending: 8.5% ‚Üí 6.8% over time
   - Remove CKD markers (normal creatinine/BUN)
   - Add thyroid function tests
   - Adjust lipid panels

3. **Update Section 6: Encounters** (2-3 hours)
   - Add mastectomy admission (2012)
   - Add chemotherapy admissions (2012-2013)
   - Add diabetes management admission (2019)
   - Remove psychiatric/substance abuse admissions

4. **Update Section 7: Clinical Notes** (3-4 hours)
   - Add oncology notes (surveillance mammograms)
   - Add diabetes educator notes
   - Add endocrinology notes (hypothyroidism)
   - Remove psychiatric crisis notes

5. **Verify Section 8.4: Patient Flags** (30 minutes)
   - Confirm Diabetes Management flag present
   - Confirm Cancer Survivor flag present
   - Remove Bailey's flags (Suicide Risk, Opioid Risk)

### Testing and Validation

1. **Run updated SQL script** in SQL Server
2. **Run full ETL pipeline** (Bronze ‚Üí Silver ‚Üí Gold ‚Üí PostgreSQL)
3. **Verify data in PostgreSQL**:
   ```sql
   -- Check Alananah's data
   SELECT * FROM clinical.patient_demographics WHERE icn = 'ICN200002';
   SELECT * FROM clinical.patient_problems WHERE icn = 'ICN200002';
   SELECT * FROM clinical.patient_medications WHERE patient_icn = 'ICN200002';
   SELECT COUNT(*) FROM clinical.patient_vitals WHERE patient_icn = 'ICN200002'; -- Should be ~60
   SELECT COUNT(*) FROM clinical.patient_encounters WHERE patient_icn = 'ICN200002'; -- Should be ~8
   ```

4. **Test AI/ML queries** with Alananah's data:
   - Patient summary generation
   - Drug-drug interaction checks
   - Vitals trend analysis
   - Clinical note summarization

### Documentation Updates

1. Update `thompson-twins-patient-reqs.md` with "implemented" status for Alananah
2. Update `thompson-twins-implementation-plan.md` with Phase 2 completion status
3. Create `thompson-alananah-testing-report.md` with validation results

---

## Summary Statistics

### Completed Updates (Phase 1)

| Section | Original (Bailey) | Updated (Alananah) | Status |
|---------|-------------------|-------------------|--------|
| **Header Comment** | Male, 100% SC, complex | Female, 50% SC, breast cancer | ‚úÖ Complete |
| **Section 1 Comment** | Male veteran | Female veteran | ‚úÖ Complete |
| **Problems** | 18 (Charlson=5) | 10 (Charlson=2) | ‚úÖ Complete |
| **Medications** | 15 active | 12 active | ‚úÖ Complete |

### Pending Updates (Phase 2)

| Section | Estimated Effort | Priority | Status |
|---------|-----------------|----------|--------|
| **Vitals** | 1-2 hours | High | üîß Pending |
| **Labs** | 2 hours | High | üîß Pending |
| **Encounters** | 2-3 hours | Medium | üîß Pending |
| **Clinical Notes** | 3-4 hours | Medium | üîß Pending |
| **Patient Flags** | 30 minutes | Low | üîß Pending |

**Total Phase 2 Effort:** 9-12 hours

---

## Document History

- **v1.0 (2026-02-09)**: Initial documentation of Phase 1 clinical updates (Problems, Medications, Header comments)
